Sunday August 9, 2020 20:59

Heathcare Press Release : 02 Mar 2020

ERBITUX(R) Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Heathcare—02 Mar 20

Approval is for ERBITUX(R)in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHNPivotal Phase III study shows significant improvements with ERBITUX(R)in combination with platinum-based therapy with

Researchers Worldwide Are Using Berkeley Lights# Beacon Platform To Combat Heathcare—02 Mar 20

Berkeley Lights' proprietary technology, the Beacon(R) optofluidic platform, is currently used by researchers across three continents—the U.S., China, and Australia—to help them find solutions for the Coronavirus Berkeley Lights, Inc.,

Researchers Worldwide Are Using Berkeley Lights# Beacon Platform To Combat Heathcare—02 Mar 20

Berkeley Lights' proprietary technology, the Beacon(R) optofluidic platform, is currently used by researchers across three continents—the U.S., China, and Australia—to help them find solutions for the Coronavirus Berkeley Lights, Inc., a